164 related articles for article (PubMed ID: 10078591)
1. The effect of transdermal estrogen replacement therapy on hyperandrogenicity and glucose homeostasis in postmenopausal women with NIDDM.
Andersson B; Mattsson LA
Acta Obstet Gynecol Scand; 1999 Mar; 78(3):260-1. PubMed ID: 10078591
[No Abstract] [Full Text] [Related]
2. The effect of continuous combined HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diabetes.
Thunell L; Andersson B; Glassell M; Mattsson LA
Maturitas; 2006 Mar; 53(4):430-8. PubMed ID: 16198072
[TBL] [Abstract][Full Text] [Related]
3. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
4. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension.
Modena MG; Rossi R; Muia N; Origliani G; Rombolà O; Molinari R
G Ital Cardiol; 1998 Jun; 28(6):636-44. PubMed ID: 9672776
[TBL] [Abstract][Full Text] [Related]
5. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxyprogesterone acetate: a 1-year, double-blind, placebo-controlled study. The Writing Group for the Estradiol Clotting Factors Study.
Thromb Haemost; 1996 Mar; 75(3):476-80. PubMed ID: 8701411
[TBL] [Abstract][Full Text] [Related]
6. Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture?
Groh KW; Stevermer JJ
J Fam Pract; 2001 Nov; 50(11):926. PubMed ID: 11711004
[No Abstract] [Full Text] [Related]
7. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
Sendağ F; Terek MC; Karadadaş N; Bilgin O
J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
[TBL] [Abstract][Full Text] [Related]
9. [A mammographic evaluation of the morphostructural variations of the breast during hormone-replacement therapy in the postmenopause].
Porfiri LM; Costanza L; De Felice C; Perrone G; David V; Zichella L
Radiol Med; 1998 Jun; 95(6):573-6. PubMed ID: 9717537
[TBL] [Abstract][Full Text] [Related]
10. Insulin sensitivity during postmenopausal hormone replacement with transdermal estradiol and intrauterine levonorgestrel.
Raudaskoski T; Tomás C; Laatikainen T
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):540-5. PubMed ID: 10376866
[TBL] [Abstract][Full Text] [Related]
11. Influence of hormone replacement therapy (17 beta-OH estradiol and medroxyprogesterone acetate) on plasma concentration of prothrombin fragment F1+2 and thrombin-antithrombin III complex in postmenopausal woman.
Ciepłluch R; Czestochowska E
Acta Haematol Pol; 1996; 27(1):21-5. PubMed ID: 8629439
[TBL] [Abstract][Full Text] [Related]
12. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
Ettinger B; Pressman A
Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
[TBL] [Abstract][Full Text] [Related]
13. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
Chu MC; Cosper P; Nakhuda GS; Lobo RA
Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346
[TBL] [Abstract][Full Text] [Related]
14. Low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women.
Villa P; Suriano R; Ricciardi L; Tagliaferri V; De Cicco S; De Franciscis P; Colacurci N; Lanzone A
Fertil Steril; 2011 Jan; 95(1):158-63. PubMed ID: 20728082
[TBL] [Abstract][Full Text] [Related]
15. The effects of estrogen therapy and estrogen combined with different androgenic progestins on carbohydrate and lipid metabolism in overweight-obese younger postmenopausal women.
Demir B; Ozturkoglu E; Solaroglu A; Baskan B; Kandemir O; Karabulut E; Haberal A
Gynecol Endocrinol; 2008 Jun; 24(6):347-53. PubMed ID: 18584415
[TBL] [Abstract][Full Text] [Related]
16. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
[TBL] [Abstract][Full Text] [Related]
17. [Influence of nomegestrol acetate on the improvement of the quality of life induced by estrogen therapy in menopausal women].
Reginster JY; Zartarian M; Colau JC
Contracept Fertil Sex; 1996 Nov; 24(11):847-51. PubMed ID: 8991589
[TBL] [Abstract][Full Text] [Related]
18. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
Ichikawa J; Sumino H; Ichikawa S; Ozaki M
Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
[TBL] [Abstract][Full Text] [Related]
19. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
Rachev E
Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
[TBL] [Abstract][Full Text] [Related]
20. [Effect of hormone replacement therapy including a progestin on insulin sensitivity and lipid profile in postmenopausal women].
Grover-Páez F; Martínez-Abundis E; González-Ortiz M
Rev Med Chil; 2001 Sep; 129(9):989-94. PubMed ID: 11725479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
